Sale!

CWF19L1 Gene Spinocerebellar Ataxia Type 17 Autosomal Recessive NGS Genetic DNA Test

Original price was: R9,350.Current price is: R6,700.

-28%

If you’re experiencing unexplained coordination problems, balance issues, or have a family history of movement disorders, our CWF19L1 Gene Spinocerebellar Ataxia Type 17 test provides the answers you need. This comprehensive NGS genetic DNA test specifically detects autosomal recessive mutations in the CWF19L1 gene that cause progressive neurological conditions. For just ZAR 6,700 (regularly ZAR 9,350), you’ll receive professional genetic counselling to understand your family history and create a detailed pedigree chart. Our advanced Next Generation Sequencing technology ensures 99.9% accuracy in detecting even rare genetic variants. Early detection through this test can help you plan for the future, access appropriate treatments, and provide crucial information for family planning decisions. With results available in 3-4 weeks and nationwide coverage across South Africa, taking control of your neurological health has never been more accessible or affordable.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

CWF19L1 Ataxia DNA Test ZAR 6
CWF19L1 Gene Spinocerebellar Ataxia Type 17 Autosomal Recessive NGS Genetic DNA Test
R9,350 Original price was: R9,350.R6,700Current price is: R6,700.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Find Clarity About Hereditary Ataxia with Our Advanced Genetic Testing

When unexplained coordination problems, balance difficulties, or family history of movement disorders create uncertainty about your neurological health, our CWF19L1 Gene Spinocerebellar Ataxia Type 17 test provides the definitive answers you deserve. Many South Africans live with undiagnosed hereditary conditions that affect their quality of life – you don’t have to be one of them.

Understanding Your CWF19L1 Genetic Test

This specialised test examines the CWF19L1 gene using Next Generation Sequencing (NGS) technology to identify autosomal recessive mutations that cause Spinocerebellar Ataxia Type 17. Unlike basic genetic screens, our comprehensive analysis detects even the rarest variants with 99.9% accuracy, giving you complete confidence in your results.

Spinocerebellar ataxia refers to a group of inherited neurological disorders that progressively affect coordination, balance, and movement. The autosomal recessive pattern means both parents must carry the gene mutation for the condition to manifest in their children.

Who Should Consider This Genetic Test?

This test is particularly important if you experience:

  • Unexplained coordination problems or clumsiness
  • Progressive balance and walking difficulties
  • Family history of movement disorders or ataxia
  • Speech changes or swallowing difficulties
  • Eye movement abnormalities
  • Planning for pregnancy with family history of neurological conditions

Many patients from Johannesburg to Cape Town have found life-changing clarity through early genetic testing, allowing them to make informed decisions about their health journey.

Why Early Detection Matters for Your Health

Getting definitive answers about your genetic status provides numerous benefits:

  • Peace of Mind: Eliminate uncertainty about your neurological symptoms
  • Treatment Planning: Work with neurologists to develop appropriate management strategies
  • Family Planning: Make informed decisions about having children
  • Early Intervention: Access supportive therapies and treatments sooner
  • Genetic Counselling: Understand inheritance patterns and risks for family members

Understanding Your Test Results

Our genetic counsellors will walk you through your results with compassion and clarity:

  • Positive Result: Confirms the presence of CWF19L1 mutations – we’ll connect you with specialist neurologists and support resources
  • Negative Result: Rules out this specific form of hereditary ataxia – providing reassurance about your symptoms
  • Variant of Unknown Significance: Rare cases where we identify genetic changes with unclear impact – we provide ongoing monitoring and research updates

Remember: A positive result doesn’t define your future – it empowers you to take control of your health journey.

Affordable Genetic Testing for South Africans

Test Option Regular Price Special Price Savings
CWF19L1 Gene Test ZAR 9,350 ZAR 6,700 ZAR 2,650

Price includes genetic counselling session and comprehensive result interpretation

Considering the lifelong impact of undiagnosed neurological conditions, this investment in your health provides exceptional value and peace of mind.

Why Trust Oracle Genomics?

  • Nationwide Coverage: Accessible testing centres in Johannesburg, Cape Town, Durban, Pretoria and nationwide
  • Medical Expertise: Tests supervised by qualified neurologists and genetic specialists
  • Advanced Technology: Next Generation Sequencing ensures highest accuracy standards
  • Genetic Counselling: Professional support included with every test
  • Rapid Turnaround: Results in 3-4 weeks with ongoing support

Test Preparation & Process

Before your test, we recommend:

  • Compiling your clinical history and symptoms
  • Preparing family medical history information
  • Attending your genetic counselling session to create a detailed pedigree chart

Sample collection is simple and minimally invasive using blood draw or FTA card blood spot.

Take the First Step Toward Neurological Clarity

Don’t let uncertainty about hereditary conditions control your life. With our special pricing of ZAR 6,700 and comprehensive support services, getting answers has never been more accessible.



Limited Time Offer: This special pricing won’t last forever. Secure your neurological health assessment today.

Nationwide Accessibility

We serve patients across South Africa with testing facilities in major centres including Johannesburg, Cape Town, Durban, Pretoria, Port Elizabeth, and Bloemfontein. Remote consultations and sample collection options available for patients outside major metropolitan areas.